Arsenic metabolism in hyperbilirubinemic rats. Distribution and excretion in relation to transformation

Arsenic Exposure and Health Effects V

Volumn , Issue , 2003, Pages 355-367

  Suzuki, Kazuo T ^a   Tomita, Takayuki ^a   Ogra, Yasumitsu ^a   Ohmichi, Masayoshi ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Arsenic; Arsenite; Dimethylated arsenic; Hyperbilirubinemic rat; Metabolism of arsenic; Rat

Indexed keywords

EID: 84942576381     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1016/B978-044451441-7/50028-2     Document Type: Article

References (38)

1. Aposhian H.V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 1997, 37:397-419.
2. Aposhian H.V., Gurzau E.S., Le X.R., Gurau A., Haly S.M., Lu X., Ma M., Yip L., Zakharyan R.A., Mariorino R.M., Dart R.C., Tircus M.G., Gonzalez-Ramirez D., Morgam D.L., Avram D., Aposhian M.M. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 2000, 13:693-697.
3. 74As]arsenic acid in the hamster. Toxicol. Lett. 1980, 5:175-182.
4. Cherrington N.J., Hartley D.P., Li N., Johnson D.R., Klaassen C.D. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J. Pharmacol. Exp. Ther. 2002, 300:97-104.
5. Cullen W.R., Mcbride B.C., Reglinski J. The reaction of methylarsenicals with thiols: some biological implications. J. Inorg. Biochem. 1984, 21:179-194.
6. Del Razo L.M., Styblo M., Cullen W.R., Thomas D.J. Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol. 2001, 174:282-293.
7. Fischer A.B., Buchet J.P., Lauwerys R.R. Arsenic uptake, cytotoxicity and detoxification studied in mammalian cells in culture. Arch. Toxicol. 1985, 57:168-172.
8. Goering P.L., Aposhian H.V., Mass M.J., Cebrian M., Beck B.D., Waalkes M.P. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 1999, 49:5-14.
9. Goyer R.A. Toxic effects of metals Casarett and Doull’s Toxicology. The Basic Science of Poisons 1996, 696-697. McGraw-Hill, New York. C.D. Klaassen (Ed.).
10. Gregus Z., Gyurasics A., Csanaky I. Biliary and urinary excretion of inorganic arsenic: monomethylarsonous acid as a major biliary metabolite in rats. Toxicol. Sci. 2000, 56:18-25.
11. Kala S.V., Neely M.W., Kala G., Prater C.I., Atwood D.W., Rice J.S., Lieberman M.W. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 2000, 275:33404-33408.
12. Kitchin K.Y. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 2001, 172:249-261.
13. Le X.C., Lu X., Ma M., Cullen W.R., Aposhian H.V., Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 2000, 72:5172-5177.
14. Le X.C., Ma M., Cullen W.R., Aposhian H.V., Lu X., Zheng B. Determination of monomethyl-arsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect. 2000, 108:1015-1018.
15. Lerman S., Clarkson T.W. The metabolism of arsenite and arsenate by the rat. Fundam. Appl. Toxicol. 1983, 3:309-314.
16. Leslie E.M., Deeley R.G., Cole S.P.C. Toxicological relevance of the multidrug resistance protein 1. MRP1 (ABCC1) and related transporters. Toxicology 2001, 167:3-23.
17. Lin S., Cullen W.R., Thomas D.J. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 1999, 12:924-930.
18. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic affected areas in West Bengal, India. Chem. Res. Toxicol. 2001, 14:371-378.
19. Marafante E., Vahter M. Solubility, retention, and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster. Environ. Res. 1987, 42:72-82.
20. Mitchell R.D., Ayala-Fierro F., Carter D.E. Systemic indicators of inorganic arsenic toxicity in four animal species. J. Toxicol. Environ. Health 2000, 59:119-134.
21. National Research Council Report Arsenic in Drinking Water 1999, National Academy Press, Washington, DC.
22. III) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 2000, 163:203-207.
23. 74As-labeled arsenate and arsenite for use in biological experiments. Anal. Biochem. 1977, 78:557-560.
24. Shibata Y., Morita M. Chemical forms of arsenic in the environment. Biomed. Res. Trace Elements 2000, 11:1-24.
25. III) by red blood cells. Chem. Res. Toxicol. 2001, 14:1446-1452.
26. Styblo M., Serves S.V., Cullen W.R., Thomas D.J. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 1997, 10:27-33.
27. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 2000, 74:289-299.
28. Suzuki K.T., Tomita T., Ogra Y., Ohmichi M. Glutathione-conjugated arsenicals in the potential hepatoenteric circulation in rats. Chem. Res. Toxicol. 2001, 14:1604-1611.
29. 74As) in humans following oral ingestion. Toxicol. Appl. Pharmacol. 1979, 50:319-322.
30. Vahter M. Arsenic. Biological Monitoring of Toxic Metals 1988, 303-321. Plenum Press, New York. T.W. Clarkson (Ed.).
31. Vahter M. Species differences in the metabolism of arsenic compounds. Appl. Organomet. Chem. 1994, 8:175-182.
32. Vahter M. Methylation of inorganic arsenic in different mammalian species and population groups. Sci. Prog. 1999, 82:69-88.
33. Vahter M. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol. Lett. 2000, 112-113:209-217.
34. Vahter M., Marafante E. Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. Chem. Biol. Interact. 1983, 47:29-44.
35. 74As-dimethylarsinic acid in mice and rats. Arch. Environ. Contam. Toxicol. 1984, 13:259-264.
36. Vahter M., Marafante E., Dencker L. Metabolism of arsenobetaine in mice, rats and rabbits. Sci. Total Environ. 1984, 30:197-211.
37. WHO Arsenic Compounds Environmental Health Criteria 224 2001, World Health Organisation, Geneva. 2nd edn.
38. Yamauchi H., Fowler B.A. Toxicity and metabolism of inorganic and methylated arsenicals. Arsenic in the Environment, Part II: Human Health and Ecosystem Effects 1994, 33-43. Wiley, New York. J.O. Nriagu (Ed.).